BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10533314)

  • 1. Receptor modulators of B-cell receptor signalling--CD19/CD22.
    Smith KG; Fearon DT
    Curr Top Microbiol Immunol; 2000; 245(1):195-212. PubMed ID: 10533314
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop.
    Fujimoto M; Bradney AP; Poe JC; Steeber DA; Tedder TF
    Immunity; 1999 Aug; 11(2):191-200. PubMed ID: 10485654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment.
    Cyster JG; Goodnow CC
    Immunity; 1997 May; 6(5):509-17. PubMed ID: 9175829
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1.
    Doody GM; Dempsey PW; Fearon DT
    Curr Opin Immunol; 1996 Jun; 8(3):378-82. PubMed ID: 8793993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux.
    Poe JC; Fujimoto M; Jansen PJ; Miller AS; Tedder TF
    J Biol Chem; 2000 Jun; 275(23):17420-7. PubMed ID: 10748054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-receptors on B lymphocytes.
    Tsubata T
    Curr Opin Immunol; 1999 Jun; 11(3):249-55. PubMed ID: 10375550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognate B cell signaling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signaling by CD22.
    Mills DM; Stolpa JC; Cambier JC
    J Immunol; 2004 Jan; 172(1):195-201. PubMed ID: 14688326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The B cell antigen receptor complex: mechanisms and implications of tyrosine kinase activation.
    Tseng J; Lee YJ; Eisfelder BJ; Clark MR
    Immunol Res; 1994; 13(4):299-310. PubMed ID: 7542303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.
    Tedder TF; Tuscano J; Sato S; Kehrl JH
    Annu Rev Immunol; 1997; 15():481-504. PubMed ID: 9143697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin.
    Tooze RM; Doody GM; Fearon DT
    Immunity; 1997 Jul; 7(1):59-67. PubMed ID: 9252120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD22 is a negative regulator of B-cell receptor signalling.
    Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
    Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice.
    Sato S; Miller AS; Inaoki M; Bock CB; Jansen PJ; Tang ML; Tedder TF
    Immunity; 1996 Dec; 5(6):551-62. PubMed ID: 8986715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19 and CD22 regulate a B lymphocyte signal transduction pathway that contributes to autoimmunity.
    Tedder TF; Sato S; Poe JC; Fujimoto M
    Keio J Med; 2000 Mar; 49(1):1-13. PubMed ID: 10750375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the B cell by CD22: a requirement for Lyn.
    Smith KG; Tarlinton DM; Doody GM; Hibbs ML; Fearon DT
    J Exp Med; 1998 Mar; 187(5):807-11. PubMed ID: 9480991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs.
    Nitschke L; Floyd H; Crocker PR
    Scand J Immunol; 2001 Mar; 53(3):227-34. PubMed ID: 11251878
    [No Abstract]   [Full Text] [Related]  

  • 20. The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes.
    Fearon DT
    Curr Opin Immunol; 1993 Jun; 5(3):341-8. PubMed ID: 7688513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.